22 April 2025 - The MHRA has approved the medicine marstacimab (Hympavzi) to prevent or reduce bleeding in patients 12 years ...
11 April 2025 - We've published final draft guidance recommending capivasertib with fulvestrant, which means the treatment will be funded immediately ...
9 April 2025 - The MHRA has today approved trastuzumab deruxtecan (Enhertu) to treat people with solid tumours that have ...
10 April 2025 - Today, for the first time, we have given the green light to a targeted treatment for the ...
9 April 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
31 March 2025 - The aim of this policy article is twofold: (i) to provide a summary and update of recent ...
2 April 2025 - NICE has published final evidence-based recommendations on the use of efanesoctocog alfa (Altuvoct) for the treatment ...
24 March 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
27 March 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
28 March 2025 - The MHRA has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...
13 March 2025 - Leniolisib is the first ever treatment for activated phosphoinositide 3-kinase delta syndrome licensed for use in the ...
13 March 2025 - Today we've recommended the first long-term daily pill to treat endometriosis that could transform how this painful ...
12 March 2025 - NICE is unable to make a recommendation on the use of atezolizumab (Tecentriq) in the NHS for ...
12 March 2025 - NICE has published final evidence-based recommendations on the use of zolbetuximab (Vyloy) in combination with chemotherapy ...
12 March 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...